These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
440 related articles for article (PubMed ID: 10188144)
1. Efficacy and safety of mizolastine 10 mg in a placebo-controlled comparison with loratadine in chronic idiopathic urticaria: results of the MILOR Study. Dubertret L; Murrieta Aguttes M; Tonet J J Eur Acad Dermatol Venereol; 1999 Jan; 12(1):16-24. PubMed ID: 10188144 [TBL] [Abstract][Full Text] [Related]
2. Comparative therapeutic effect and safety of mizolastine and loratadine in chronic idiopathic urticaria. URTILOR study group. Leynadier F; Duarte-Risselin C; Murrieta M Eur J Dermatol; 2000; 10(3):205-11. PubMed ID: 10725819 [TBL] [Abstract][Full Text] [Related]
3. Mizolastine provides effective symptom relief in patients suffering from perennial allergic rhinitis: a double-blind, placebo-controlled study versus loratadine. Frèche C; Leynadier F; Horak F; Hide D; Gracia FD; Goos M; Bachert C; Horvath A; Antosova E; Verrecchia M; Soussen PB Ann Allergy Asthma Immunol; 2002 Sep; 89(3):304-10. PubMed ID: 12269652 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of mizolastine, a new antihistamine, compared with placebo in the treatment of chronic idiopathic urticaria. Brostoff J; Fitzharris P; Dunmore C; Theron M; Blondin P Allergy; 1996 May; 51(5):320-5. PubMed ID: 8836336 [TBL] [Abstract][Full Text] [Related]
5. Comparison of mizolastine with loratadine in the treatment of perennial allergic rhinitis. Bellioni P; Catalano B; Cervellera G; Filiaci F; Mira E; Carraro A Rhinology; 1996 Jun; 34(2):101-4. PubMed ID: 8876072 [TBL] [Abstract][Full Text] [Related]
6. Emedastine difumarate versus loratadine in chronic idiopathic urticaria: a randomized, double-blind, controlled European multicentre clinical trial. Pons-Guiraud A; Nekam K; Lahovsky J; Costa A; Piacentini A Eur J Dermatol; 2006; 16(6):649-54. PubMed ID: 17229605 [TBL] [Abstract][Full Text] [Related]
7. Cetirizine, loratadine, or placebo in subjects with seasonal allergic rhinitis: effects after controlled ragweed pollen challenge in an environmental exposure unit. Day JH; Briscoe M; Widlitz MD J Allergy Clin Immunol; 1998 May; 101(5):638-45. PubMed ID: 9600501 [TBL] [Abstract][Full Text] [Related]
8. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria. Monroe EW; Bernstein DI; Fox RW; Grabiec SV; Honsinger RW; Kalivas JT; Katz HI; Cuss F; Danzig MR; Garvin PR Arzneimittelforschung; 1992 Sep; 42(9):1119-21. PubMed ID: 1445478 [TBL] [Abstract][Full Text] [Related]
9. Levocetirizine in the treatment of chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Barra L; Ferrannini A; Vacca A; Tursi A Br J Dermatol; 2006 Mar; 154(3):533-8. PubMed ID: 16445787 [TBL] [Abstract][Full Text] [Related]
10. A double-blind, randomized, single-dose, crossover comparison of levocetirizine with ebastine, fexofenadine, loratadine, mizolastine, and placebo: suppression of histamine-induced wheal-and-flare response during 24 hours in healthy male subjects. Grant JA; Riethuisen JM; Moulaert B; DeVos C Ann Allergy Asthma Immunol; 2002 Feb; 88(2):190-7. PubMed ID: 11868924 [TBL] [Abstract][Full Text] [Related]
11. Relative efficacy and safety of loratadine, hydroxyzine, and placebo in chronic idiopathic urticaria and atopic dermatitis. Monroe EW Clin Ther; 1992; 14(1):17-21. PubMed ID: 1349509 [TBL] [Abstract][Full Text] [Related]
12. Levocetirizine for the treatment of allergic rhinitis and chronic idiopathic urticaria in adults and children. Singh-Franco D; Ghin HL; Robles GI; Borja-Hart N; Perez A Clin Ther; 2009 Aug; 31(8):1664-87. PubMed ID: 19808127 [TBL] [Abstract][Full Text] [Related]
13. Levocetirizine is an effective treatment in patients suffering from chronic idiopathic urticaria: a randomized, double-blind, placebo-controlled, parallel, multicenter study. Kapp A; Pichler WJ Int J Dermatol; 2006 Apr; 45(4):469-74. PubMed ID: 16650180 [TBL] [Abstract][Full Text] [Related]
14. Comparative effects of loratadine and terfenadine in the treatment of chronic idiopathic urticaria. Belaich S; Bruttmann G; DeGreef H; Lachapelle JM; Paul E; Pedrali P; Tennstedt D Ann Allergy; 1990 Feb; 64(2 Pt 2):191-4. PubMed ID: 1967919 [TBL] [Abstract][Full Text] [Related]
15. Once-daily rupatadine improves the symptoms of chronic idiopathic urticaria: a randomised, double-blind, placebo-controlled study. Dubertret L; Zalupca L; Cristodoulo T; Benea V; Medina I; Fantin S; Lahfa M; Pérez I; Izquierdo I; Arnaiz E Eur J Dermatol; 2007; 17(3):223-8. PubMed ID: 17478385 [TBL] [Abstract][Full Text] [Related]
16. Once-daily fexofenadine treatment for chronic idiopathic urticaria: a multicenter, randomized, double-blind, placebo-controlled study. Kaplan AP; Spector SL; Meeves S; Liao Y; Varghese ST; Georges G Ann Allergy Asthma Immunol; 2005 Jun; 94(6):662-9. PubMed ID: 15984599 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled study. Ratner P; Hampel F; Van Bavel J; Howland W Int Arch Allergy Immunol; 2004 Apr; 133(4):371-9. PubMed ID: 15031611 [TBL] [Abstract][Full Text] [Related]
18. Randomized placebo-controlled trial comparing desloratadine and montelukast in monotherapy and desloratadine plus montelukast in combined therapy for chronic idiopathic urticaria. Di Lorenzo G; Pacor ML; Mansueto P; Esposito Pellitteri M; Lo Bianco C; Ditta V; Martinelli N; Rini GB J Allergy Clin Immunol; 2004 Sep; 114(3):619-25. PubMed ID: 15356567 [TBL] [Abstract][Full Text] [Related]
19. Desloratadine in combination with montelukast in the treatment of chronic urticaria: a randomized, double-blind, placebo-controlled study. Nettis E; Colanardi MC; Paradiso MT; Ferrannini A Clin Exp Allergy; 2004 Sep; 34(9):1401-7. PubMed ID: 15347373 [TBL] [Abstract][Full Text] [Related]